Variables | Training cohort (n = 211) | Internal validation cohort (n = 30) |
---|---|---|
Age (years) | 50.0 ± 11.4 | 50.0 ± 13.1 |
Gender, M: F | 200:11 | 26:4 |
HBsAg | ||
Positive | 203 (96.2%) | 28 (93.3%) |
Negative | 8 (3.8%) | 2 (6.7%) |
AFP (ng/ml) | 380.4 ± 519.4 | 326.3 ± 455.2 |
Platelet count (109/L) | 175.3 ± 78.8 | 202.3 ± 86.6 |
Prothrombin time (s) | 13.6 ± 1.3 | 13.5 ± 1.3 |
Total bilirubin (μmol/L) | 17.6 ± 13.2 | 14.7 ± 9.4 |
Albumin (g/L) | 39.8 ± 4.4 | 39.6 ± 4.8 |
Alanine aminotransferase (U/L) | 48.6 ± 42.7 | 48.9 ± 28.7 |
Child–Pugh score | ||
A | 210 (99.5%) | 28 (93.3%) |
B | 1 (0.5%) | 2 (6.7%) |